These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6162646)

  • 21. Chemotherapy of disseminated testicular cancer.
    Williams SD; Einhorn LH
    Ariz Med; 1978 Sep; 35(9):595-7. PubMed ID: 81667
    [No Abstract]   [Full Text] [Related]  

  • 22. Variables for predicting serious toxicity (vinblastine dose, performance status, and prior therapeutic experience): chemotherapy for metastatic testicular cancer with cis-dichlorodiammineplatinum(II), vinblastine, and bleomycin.
    Krikorian JG; Daniels JR; Brown BW; Hu MS
    Cancer Treat Rep; 1978 Oct; 62(10):1455-63. PubMed ID: 81719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fatal coronary artery fibrosis after treatment with bleomycin, vinblastine, and cis-platinum.
    Bodensteiner DC
    South Med J; 1981 Jul; 74(7):898-9. PubMed ID: 6166992
    [No Abstract]   [Full Text] [Related]  

  • 24. Vinblastine, intermittent bleomycin, and single-dose cis-dichlorodiammineplatinum(II) in the management of stge III testicular cancer.
    Bosl GJ; Kwong R; Lange PH; Fraley EE; Kennedy BJ
    Cancer Treat Rep; 1980; 64(2-3):331-4. PubMed ID: 6157467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination chemotherapy with cis-diammine-dichloro-platinum, vinblastine, and bleomycin in advanced testicular non-seminoma.
    Stoter G; Sleijfer DT; Vendrik CP; Schraffordt Koops H; Struyvenberg A; Van Oosterom AT; Brouwers TM; Pinedo HM
    Lancet; 1979 May; 1(8123):941-5. PubMed ID: 87614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced platelet survival following chemotherapy with vinblastine, bleomycin and cis-platinum for testicular teratoma.
    Rees GJ; Slade RR; Hopes P
    Eur J Cancer Clin Oncol; 1982 Nov; 18(11):1125-9. PubMed ID: 6186497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclic chemotherapy with cyclophosphamide, doxorubicin, and cisplatin plus vinblastine and bleomycin in advanced germinal tumors. Results with 100 patients.
    Logothetis CJ; Samuels ML; Selig DE; Ogden S; Dexeus F; Swanson D; Johnson D; von Eschenbach A
    Am J Med; 1986 Aug; 81(2):219-28. PubMed ID: 2426944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experience with PVB in non seminomatous germ-cell cancer of the testis.
    Jacquillat C; Auclerc G; Auclerc MF; Verges J; Weil M
    Prog Clin Biol Res; 1985; 203():451-6. PubMed ID: 2421336
    [No Abstract]   [Full Text] [Related]  

  • 29. Long-term treatment with cis-dichlorodiammineplatinum(II)-vinblastine-bleomycin: possible association with severe coronary artery disease.
    Edwards GS; Lane M; Smith FE
    Cancer Treat Rep; 1979 Apr; 63(4):551-2. PubMed ID: 87274
    [No Abstract]   [Full Text] [Related]  

  • 30. Long-term effects on renal function and blood pressure of treatment with cisplatin, vinblastine, and bleomycin in patients with germ cell cancer.
    Hansen SW; Groth S; Daugaard G; Rossing N; Rørth M
    J Clin Oncol; 1988 Nov; 6(11):1728-31. PubMed ID: 2460594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of cisplatin + bleomycin + either vinblastine or VP-16 in disseminated testicular cancer: a preliminary report.
    Williams SD; Birch R; Greco FA; Einhorn LH
    Prog Clin Biol Res; 1984; 153():219-23. PubMed ID: 6206507
    [No Abstract]   [Full Text] [Related]  

  • 32. Raynaud's phenomenon as a side effect of chemotherapy with vinblastine and bleomycin for testicular carcinoma.
    Teutsch C; Lipton A; Harvey HA
    Cancer Treat Rep; 1977 Aug; 61(5):925-6. PubMed ID: 70274
    [No Abstract]   [Full Text] [Related]  

  • 33. Influence of combination chemotherapy with cis-diamminedichloroplatinum on renal function: long-term effects.
    Meijer S; Mulder NH; Sleijfer DT; Donker AJ; Sluiter WJ; de Jong PE; Schraffordt Koops H; van der Hem GK
    Oncology; 1983; 40(3):170-3. PubMed ID: 6189040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized trial of cisplatin, vinblastine, and bleomycin versus vinblastine, cisplatin, and etoposide in the treatment of advanced germ cell tumors of the testis: a Southwest Oncology Group study.
    Wozniak AJ; Samson MK; Shah NT; Crawford ED; Ford CD; Altman SJ; Stephens RL; Natale RB; Bouroncle BA; Blumenstein BA
    J Clin Oncol; 1991 Jan; 9(1):70-6. PubMed ID: 1702148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selected use of aggressive adjuvant chemotherapy in resected stage II nonseminomatous germ cell tumors of the testis.
    Pizzocaro G
    Prog Clin Biol Res; 1985; 203():585-90. PubMed ID: 2421344
    [No Abstract]   [Full Text] [Related]  

  • 36. Improved chemotherapy in disseminated testicular cancer.
    Einhorn LH; Donohue JP
    J Urol; 1977 Jan; 117(1):65-9. PubMed ID: 63574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urinary excretion of alanine-aminopeptidase and N-acetyl-beta-D-glucosaminidase during sequential combination chemotherapy.
    Diener U; Knoll E; Ratge D; Langer B; Wisser H
    J Clin Chem Clin Biochem; 1982 Sep; 20(9):615-9. PubMed ID: 6183389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Raynaud's phenomenon: a common toxicity after combination chemotherapy for testicular cancer.
    Vogelzang NJ; Bosl GJ; Johnson K; Kennedy BJ
    Ann Intern Med; 1981 Sep; 95(3):288-92. PubMed ID: 6168223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bleomycin in germ cell testicular tumors (GCTT).
    Germa Lluch JR
    Prog Clin Biol Res; 1985; 203():381-9. PubMed ID: 2421332
    [No Abstract]   [Full Text] [Related]  

  • 40. Vinblastine (VLB), bleomycin (BLEO), cis-diamminedichloroplatinum (DDP) in disseminated extragonadal germ cell tumors. A Southwest Oncology Group Study.
    Feun LG; Samson MK; Stephens RL
    Cancer; 1980 May; 45(10):2543-9. PubMed ID: 6155194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.